Lilly pays $90 million for autoimmune drug
By acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on autoimmune
diseases.
Health Care & Life Sciences
Articles
Health Care bill clears key Senate test
Landmark health care legislation backed by President Barack Obama passed its sternest Senate test in the pre-dawn hours early
Monday, overcoming Republican delaying tactics on a 60-40 vote that all but assures its passage by Christmas.
Building trades leaders flock to Wishard meetings
Hundreds of potential contractors turned out for informational meetings this week about construction work on a new Wishard Memorial Hospital.
Hoosier biz groups oppose Senate health bill
Group presidents tell Indiana senators that the reform bill would expand dysfunctions of current health care systems.
Setbacks in diabetes market batter Roche
Roche Diagnostics Corp., once the darling of the U.S. diabetes-device market, is now licking its wounds. And
it’s mulling whether to keep fighting on all fronts or to pull back.
Judge fines woman waging Web war against plastic surgeon
Judge Sarah Evans Barker declared a Massachusetts woman in contempt of court for failing to remove her negative Internet
postings about an Indianapolis cosmetic surgeon.
First Indiana Future Fund off to a slow start
More than half of the venture capital fund’s original investors took a pass on its $58 million successor, the newly launched
INext.
Senate rejects drug-importation proposal
The U.S. Senate voted down a plan Tuesday to allow Americans to import prescriptions from abroad, handing drug makers
such as Indianapolis-based Eli Lilly and Co. a victory.
$60M Lilly Endowment grant to fund IU physician research
Indiana University, which has received nearly $600 million from the endowment over the last three decades, will leverage the
new gift to increase its
scientific discoveries and commercialize life science innovations.
Lilly wins approval for long-acting Zyprexa
Once-a-month injection of best-selling drug will have patents that could extend until 2018.
Dormir acquires two sleep companies
Carmel firm using $12 million in venture capital for buying spree is now nation’s second-largest operator of sleep centers.
Lilly charity gives $1M to new IU health school
The Eli Lilly and Co. Foundation has given Indiana University $1 million to start a school of public health at Indiana University-Purdue
University Indianapolis.
Noble of Indiana to provide in-home services to disabled
The service will launch in February. Its goal is to serve 15 clients by June 30, 2010.
Health care reform would push state to hike Medicaid pay to docs
An actuarial report prepared by the local office of Milliman Inc., a Seattle-based consulting firm, projects
that the state of Indiana would have to hike its Medicaid payments by one-third in order to entice more
doctors into the program.
Plainfield’s MD Logistics sued by Bristol-Myers over lost insulin
Two semi-trailers of the medication were stolen in 2007 from a back lot at Daum Trucking, which isn’t named in the lawsuit.
Bristol-Myers charges MD Logistics with negligence in the $10.7 million suit.
Eli Lilly’s shares slip after it forecasts mixed profits in coming years
The Indianapolis-based drugmaker predicts strong profits through 2011, but its forecast for 2012 suggests bottom-line results
could fall precipitously.
Lilly launching new venture capital fund
The fund would acquire experimental drugs and use Lilly R&D staff to try to prove their effectiveness, perhaps boosting Lilly’s drug pipeline.
HealthNet lands $10.5 million in stimulus funds
HealthNet said it will use the funds to expand and renovate two community health centers that have outgrown their space.
Lilly forecasts growth in earnings next year
Eli Lilly and Co. said it still expects its earnings per share to grow in the double-digit range through 2011.
Company’s medical device earns expedited review
FAST Diagnostics LLC said initial human trials on its method to measure kidney function faster and more accurately than existing
techniques could begin as early as next year, with commercialization following by 2012.